Last updated: 2026-09-16 12:18:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Sanara MedTech Inc. (SMTI) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $35.11, with a market capitalisation of $321.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.05 to $35.53. This page covers its latest market performance, valuation, price trends and company information.
$321.40M | |
$35.09 | |
$53.85 | |
$5.00 | |
$35.11 | |
-- | |
254.27K | |
-- | |
$35.53 | |
$16.05 | |
-- | |
-- |
Sanara MedTech Inc. (SMTI) is trading at $35.11 in pre-market trading as of 2026-09-16 08:04:00, down 0.00% ($0.00) from the previous close of $35.11
Pre-market trading shows how investors are pricing SMTI before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Sanara MedTech Inc. (SMTI) moved from $34.73 to $35.11, representing a gain of 1.09% ($0.38).
The stock traded between $34.62 and $35.24 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 276.98 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 97.9%
SMTI is currently trading at $35.11, placing it 97.9% of the way from its 52-week low of $16.05 to its 52-week high of $35.53. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 108 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sanara MedTech Inc. (SMTI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.